iCARE Rapid Respiratory Combo Antigen Rapid Test (COVID-19/RSV/ADV/FLU)


iCARE Rapid Respiratory Combo Antigen Rapid Test (COVID-19/RSV/ADV/FLU)

Jal Medical is renowned as one of the leading manufacturers, exporters, and suppliers of the iCARE Rapid Respiratory Combo Antigen Rapid Test (COVID-19/RSV/ADV/FLU) with the COVID-19/RSV/ADV/FLU/MP Antigen Rapid Test (Nasal). This rapid test is specifically designed for the qualitative detection of multiple respiratory viruses, including SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus, and Mycoplasma pneumoniae, from anterior nasal swab specimens. This test is for professional in vitro diagnostic use only, ensuring reliable results for healthcare providers.

The iCARE Rapid Respiratory Combo Antigen Rapid Test is essential for accurately diagnosing respiratory viral infections, which often present similar symptoms. This test utilizes a lateral flow immunoassay technique, providing results within 15-30 minutes. By identifying and differentiating between various pathogens, healthcare professionals can administer the appropriate treatments promptly, thereby improving patient outcomes and reducing the spread of infections.

Rapid Respiratory Combo Antigen Rapid Test Key Features

  • Rapid Results: Provides results within 15-30 minutes.
  • Multi-Pathogen Detection: Simultaneous detection of SARS-CoV-2, Influenza A and B, RSV, Adenovirus, and Mycoplasma pneumoniae.
  • Easy to Use: Requires only an anterior nasal swab specimen.
  • Professional Use: Intended for use by healthcare professionals for in vitro diagnostics.
  • Compact Kits: Available in 1 Test/Kit and 20 Tests/Kit formats.

Importance of Early Detection

Respiratory viral infections, such as those caused by SARS-CoV-2 and Influenza, can lead to severe health complications if not promptly diagnosed and treated. The iCARE Rapid Respiratory Combo Antigen Rapid Test from Jal Medical helps differentiate between these infections early on, allowing healthcare providers to implement effective treatment plans. Early diagnosis is particularly crucial for high-risk groups, including the elderly, infants, and individuals with compromised immune systems.

Jal Medical ensures that each test kit is manufactured to the highest standards, providing reliable and accurate results. With extensive distribution networks, Jal Medical supplies these rapid test kits to healthcare facilities across 57 African countries and various regions, including the Caribbean and Central Asia. This widespread availability ensures that communities worldwide have access to essential diagnostic tools to combat respiratory infections effectively.